The Therapeutic Effect of Cytokine-Induced Killer Cells on Pancreatic Cancer Enhanced by Dendritic Cells Pulsed with K-Ras Mutant Peptide
Objective. This study is to investigate the role of the CIKs cocultured with K-ras-DCs in killing of pancreatic cancer cell lines, PANC-1 (K-ras+) and SW1990 (K-ras−). Methods. CIKs induced by IFN-γ, IL-2, and anti-CD3 monoantibody, K-ras-DCCIKs obtained by cocultivation of k-ras-DCs and CIKs. Surf...
Saved in:
| Main Authors: | Guang Tan, Xin Zhang, Hongbo Feng, Haifeng Luo, Zhongyu Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2011/649359 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HLA I immunopeptidome of synthetic long peptide pulsed human dendritic cells for therapeutic vaccine design
by: Amy L. Kessler, et al.
Published: (2025-01-01) -
Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials
by: Wendi Jiang, et al.
Published: (2024-12-01) -
MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells
by: Min Dong, et al.
Published: (2023-01-01) -
Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01) -
Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours
by: Paul Dent, et al.
Published: (2022-09-01)